Tracey E Schefter

Summary

Affiliation: University of Colorado Denver
Country: USA

Publications

  1. doi request reprint RTOG 0417: efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma
    Tracey Schefter
    University of Colorado, Denver, Aurora, Colorado Electronic address
    Int J Radiat Oncol Biol Phys 88:101-5. 2014
  2. doi request reprint A phase II study of bevacizumab in combination with definitive radiotherapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma: preliminary results of RTOG 0417
    Tracey E Schefter
    University of Colorado Denver, Aurora, CO, USA
    Int J Radiat Oncol Biol Phys 83:1179-84. 2012
  3. doi request reprint Radiation therapy for liver metastases
    Tracey E Schefter
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO 80045, USA
    Semin Radiat Oncol 21:264-70. 2011
  4. doi request reprint Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases
    Kyle E Rusthoven
    University of Colorado Denver, Department of Radiation Oncology and Medical Oncology, Aurora, CO 80045, USA
    J Clin Oncol 27:1579-84. 2009
  5. ncbi request reprint Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer
    Brian D Kavanagh
    Department of Radiation Oncology, University of Colorado Health Sciences Center, Aurora, CO 80010 0510, USA
    Semin Radiat Oncol 12:260-71. 2002
  6. doi request reprint Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trial
    Ari Ballonoff
    Department of Radiation Oncology, University of Colorado Health Sciences Center, Aurora, CO 80045 0508, USA
    Am J Clin Oncol 31:264-70. 2008
  7. doi request reprint Normal liver tissue density dose response in patients treated with stereotactic body radiation therapy for liver metastases
    Christopher C Howells
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO 80045, USA
    Int J Radiat Oncol Biol Phys 84:e441-6. 2012
  8. doi request reprint Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy
    Robert McCammon
    Department of Radiation Oncology, University of Colorado Health Sciences Center, Aurora, CO, USA
    Int J Radiat Oncol Biol Phys 73:112-8. 2009
  9. doi request reprint Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases
    Kyle E Rusthoven
    University of Colorado Denver, Department of Radiation Oncology, Pathology, and Medical Oncology, Aurora, CO 80045, USA
    J Clin Oncol 27:1572-8. 2009
  10. doi request reprint Results of a phase I trial of 12 patients with locally advanced pancreatic carcinoma combining gefitinib, paclitaxel, and 3-dimensional conformal radiation: report of toxicity and evaluation of circulating K-ras as a potential biomarker of response to the
    Christine C Olsen
    Department of Radiation Oncology, University of Colorado Denver Health Sciences Center, Aurora, CO, USA
    Am J Clin Oncol 32:115-21. 2009

Detail Information

Publications22

  1. doi request reprint RTOG 0417: efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma
    Tracey Schefter
    University of Colorado, Denver, Aurora, Colorado Electronic address
    Int J Radiat Oncol Biol Phys 88:101-5. 2014
    ..Herein we report the secondary efficacy endpoints of overall survival (OS), locoregional failure (LRF), para-aortic nodal failure (PAF), distant failure (DF), and disease-free survival (DFS)...
  2. doi request reprint A phase II study of bevacizumab in combination with definitive radiotherapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma: preliminary results of RTOG 0417
    Tracey E Schefter
    University of Colorado Denver, Aurora, CO, USA
    Int J Radiat Oncol Biol Phys 83:1179-84. 2012
    ..Concurrent cisplatin-based chemoradiotherapy (CRT) is the standard treatment for locally advanced cervical cancer. RTOG 0417 was a Phase II study exploring the safety and efficacy of the addition of bevacizumab to standard CRT...
  3. doi request reprint Radiation therapy for liver metastases
    Tracey E Schefter
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO 80045, USA
    Semin Radiat Oncol 21:264-70. 2011
    ..There is growing evidence that strategies using aggressive or ablative local therapies as an adjunct to systemic therapy might achieve improvements in overall outcome as long as they are administered safely...
  4. doi request reprint Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases
    Kyle E Rusthoven
    University of Colorado Denver, Department of Radiation Oncology and Medical Oncology, Aurora, CO 80045, USA
    J Clin Oncol 27:1579-84. 2009
    ..To evaluate the efficacy and tolerability of high-dose stereotactic body radiation therapy (SBRT) for the treatment of patients with one to three lung metastases...
  5. ncbi request reprint Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer
    Brian D Kavanagh
    Department of Radiation Oncology, University of Colorado Health Sciences Center, Aurora, CO 80010 0510, USA
    Semin Radiat Oncol 12:260-71. 2002
    ....
  6. doi request reprint Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trial
    Ari Ballonoff
    Department of Radiation Oncology, University of Colorado Health Sciences Center, Aurora, CO 80045 0508, USA
    Am J Clin Oncol 31:264-70. 2008
    ....
  7. doi request reprint Normal liver tissue density dose response in patients treated with stereotactic body radiation therapy for liver metastases
    Christopher C Howells
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO 80045, USA
    Int J Radiat Oncol Biol Phys 84:e441-6. 2012
    ..To evaluate the temporal dose response of normal liver tissue for patients with liver metastases treated with stereotactic body radiation therapy (SBRT)...
  8. doi request reprint Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy
    Robert McCammon
    Department of Radiation Oncology, University of Colorado Health Sciences Center, Aurora, CO, USA
    Int J Radiat Oncol Biol Phys 73:112-8. 2009
    ..To determine prognostic factors for local control of primary or metastatic tumors within the lung or liver treated with stereotactic body radiation therapy (SBRT) within a single institution...
  9. doi request reprint Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases
    Kyle E Rusthoven
    University of Colorado Denver, Department of Radiation Oncology, Pathology, and Medical Oncology, Aurora, CO 80045, USA
    J Clin Oncol 27:1572-8. 2009
    ..To evaluate the efficacy and tolerability of high-dose stereotactic body radiation therapy (SBRT) for the treatment of patients with one to three hepatic metastases...
  10. doi request reprint Results of a phase I trial of 12 patients with locally advanced pancreatic carcinoma combining gefitinib, paclitaxel, and 3-dimensional conformal radiation: report of toxicity and evaluation of circulating K-ras as a potential biomarker of response to the
    Christine C Olsen
    Department of Radiation Oncology, University of Colorado Denver Health Sciences Center, Aurora, CO, USA
    Am J Clin Oncol 32:115-21. 2009
    ....
  11. ncbi request reprint Interim analysis of a prospective phase I/II trial of SBRT for liver metastases
    Brian D Kavanagh
    Department of Radiation Oncology, University of Colorado, Aurora, Colorado 80045, USA
    Acta Oncol 45:848-55. 2006
    ..This interim analysis indicates that a very high rate of durable in-field tumor control can be safely achieved with SBRT to 1-3 liver lesions as administered in this protocol, to a prescription dose of 60 Gy in 3 fractions...
  12. ncbi request reprint The dosimetric effect of inhomogeneity correction in dynamic conformal arc stereotactic body radiation therapy for lung tumors
    Brian D Kavanagh
    Department of Radiation Oncology, University of Colorado, Aurora, Colorado, USA
    J Appl Clin Med Phys 7:58-63. 2006
    ..In reports of SBRT, it will be helpful to maintain clear communication about the type of IC used to avoid future uncertainties about true normal tissue tolerance and tumor dose-response relationships...
  13. doi request reprint High-dose MVCT image guidance for stereotactic body radiation therapy
    David C Westerly
    Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado 80045, USA
    Med Phys 39:4812-9. 2012
    ..The goal of this work was to investigate the use of increased imaging doses on a clinical tomotherapy machine to improve image quality for SBRT image guidance...
  14. doi request reprint Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: a surveillance, epidemiology, and end-results study
    Amanda L Schwer
    Department of Radiation Oncology, University of Colorado Health Sciences Center, Aurora, Colorado, USA
    Int J Radiat Oncol Biol Phys 73:449-55. 2009
    ..This study used a large population-based database to assess the effect of NeoRT on survival for patients treated with definitive surgery...
  15. doi request reprint Fluorodeoxyglucose positron emission tomography response and normal tissue regeneration after stereotactic body radiotherapy to liver metastases
    Michelle A Stinauer
    Department of Radiation Oncology, University of Colorado Denver, Aurora, Colorado, USA
    Int J Radiat Oncol Biol Phys 83:e613-8. 2012
    ..To characterize changes in standardized uptake value (SUV) in positron emission tomography (PET) scans and determine the pace of normal tissue regeneration after stereotactic body radiation therapy (SBRT) for solid tumor liver metastases...
  16. doi request reprint Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma
    Higinia R Cardenes
    Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis 46202, USA
    Clin Transl Oncol 12:218-25. 2010
    ..Hepatocellular carcinoma (HCC) is increasing in incidence and the majority of patients are not candidates for radical therapies. Therefore, interest in minimally invasive therapies in growing...
  17. doi request reprint Esophageal cancer patients undergoing external beam radiation after placement of self-expandable metal stents: is there a risk of radiation dose enhancement?
    Yang K Chen
    Division of Gastroenterology and Hepatology, University of Colorado Denver, Aurora, Colorado 80045 2541, USA
    Gastrointest Endosc 73:1109-14. 2011
    ..Self-expandable metal stents (SEMSs) are used for palliation of malignant dysphagia. It is not known whether dose adjustments are required when there is a stent in the radiation field...
  18. ncbi request reprint A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases
    Tracey E Schefter
    Department of Radiation Oncology, University of Colorado Health Sciences Center, Aurora, CO 80045 0510, USA
    Int J Radiat Oncol Biol Phys 62:1371-8. 2005
    ..To determine the maximum tolerated dose (MTD) of stereotactic body radiation therapy (SBRT) for liver metastases...
  19. pmc Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control
    Michelle A Stinauer
    University of Colorado Denver, School of Medicine, Aurora, Colorado, USA
    Radiat Oncol 6:34. 2011
    ..Whereas stereotactic body radiation therapy (SBRT) involves radiation dose intensification via escalation, we hypothesize SBRT might result in similar high local control rates as previously published on metastases of varying histologies...
  20. doi request reprint Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis
    Daniel T Chang
    Department of Radiation Oncology, Stanford University, Stanford, California, USA
    Cancer 117:4060-9. 2011
    ..This study was undertaken to determine outcomes of stereotactic body radiotherapy for colorectal liver metastases in a pooled patient cohort...
  21. ncbi request reprint Technical considerations in the application of intensity-modulated radiotherapy as a concomitant integrated boost for locally-advanced cervix cancer
    Tracey E Schefter
    Department of Radiation Oncology, University of Colorado Health Sciences Center, Aurora 80010 0510, USA
    Med Dosim 27:177-84. 2002
    ..This is especially relevant to the possible introduction of intrafractional movement and resulting inaccuracy, as well as facility efficiency...
  22. ncbi request reprint Triple-modality therapy for a woman with locally advanced thoracic esophageal adenocarcinoma, Part 2
    Tracey E Schefter
    Radiation Oncology, University of Colorado, Cancer Center, USA
    Oncology (Williston Park) 19:830, 835-6, 838 passim. 2005